Comparative Analysis of Two Animal-derived ADMs in Irradiated Implant-based Reconstruction
NCT ID: NCT06139588
Last Updated: 2023-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
146 participants
OBSERVATIONAL
2017-06-01
2023-10-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions the study aims to answer are:
* is one of the two matrices better than the other? (better results with fewer complications)
* is there a group of patients who benefit more than another from the use of this type of devices?
* is there an adm which works better in one specific subgroup of patients? Participants have undergone mastectomy, radiotherapy and implant reconstruction with the aid of two different kinds of acellular dermal matrices.
Researchers will compare patients who receive the porcine-derived adm and the patients who receive bovine-derived adm to see if there is a difference in terms of capsular contracture reduction, aestethic result and complications.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
POST QUART NATIVE
Native adm used in the setting of mastectomy and implant reconstruction after QUART
acellular dermal matrix implant for breast reconstruction
acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy
POST QUART VERITAS
Veritas adm used in the setting of mastectomy and implant reconstruction after QUART
acellular dermal matrix implant for breast reconstruction
acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy
POST EXPANDER NATIVE
Native adm used in the setting of expander removal and implant positioning after mastectomy + RT
acellular dermal matrix implant for breast reconstruction
acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy
POST EXPANDER VERITAS
Veritas adm used in the setting of expander removal and implant positioning after mastectomy + RT
acellular dermal matrix implant for breast reconstruction
acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy
IMPLANT EXCHANGE NATIVE
Native adm used in the setting of implant exchange after mastectomy + RT
acellular dermal matrix implant for breast reconstruction
acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy
IMPLANT EXCHANGE VERITAS
Veritas adm used in the setting of implant exchange after mastectomy + RT
acellular dermal matrix implant for breast reconstruction
acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy
IMPANT EXCHANGE AFTER QUART NATIVE
Native adm used in the setting of implant exchange after QUART+ Mastectomy and implant reconstruction
acellular dermal matrix implant for breast reconstruction
acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy
IMPLANT EXCHANGE AFTER QUART VERITAS
Veritas adm used in the setting of implant exchange after QUART+ Mastectomy and implant reconstruction
acellular dermal matrix implant for breast reconstruction
acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acellular dermal matrix implant for breast reconstruction
acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* breast reconstruction with implant + acellular dermal matrix after mastectomy and radiotherapy
Exclusion Criteria
* autoimmune disease
* prolonged use of corticosteroids
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Institute of Oncology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrea Vittorio Emanuele Lisa, MD
Role: PRINCIPAL_INVESTIGATOR
Istituto Europeo di Oncologia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
European Institute of Oncology
Milan, Lombardy, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UID4321
Identifier Type: -
Identifier Source: org_study_id